Do You Think ICON Public Limited Company (ICLR) is a High Quality Company? - InvestingChannel

Do You Think ICON Public Limited Company (ICLR) is a High Quality Company?

Baron Funds, an investment management company, released its “Baron Small Cap Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund declined 3.64% (Institutional Shares), underperforming the Russell 2000 Growth Index, which was 0.24% up, and outperforming the S&P 500 Index, which was 4.88% down. In addition, please check the fund’s top five holdings to know its best picks in 2022.

Baron Funds discussed stocks like ICON Public Limited Company (NASDAQ:ICLR) in the Q3 2022 investor letter. Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ:ICLR) is a clinical research company. On October 31, 2022, ICON Public Limited Company (NASDAQ:ICLR) stock closed at $197.84 per share. One-month return of ICON Public Limited Company (NASDAQ:ICLR) was 0.29% and its shares lost 29.94% of their value over the last 52 weeks. ICON Public Limited Company (NASDAQ:ICLR) has a market capitalization of $16.129 billion.

Here is what Baron Funds specifically said about ICON Public Limited Company (NASDAQ:ICLR)  in its Q3 2022 investor letter:

ICON Public Limited Company (NASDAQ:ICLR), a large global contract research organization that provides outsourced drug development services to the pharmaceutical industry, fell on investor concern about softer funding for biotechnology companies in conjunction with the decline of the stock market. Emerging biotechnology companies account for about 15% of ICON’s revenues, so there is risk to some of its book. However, management has not seen any deterioration and really doesn’t expect any. Otherwise, business is awesome. Organic growth, excluding revenues associated with tests for COVID drugs, was up 16% in the quarter. The integration with PRA Health Sciences is going swimmingly, and margins are expanding ahead of schedule. Though the company is delivering quickly, the balance sheet has a lot of variable rate debt, which will be more expensive as rates rise. All in, we see a high-quality, well managed, business that can grow earnings at 20% per year trading at 14 times next year’s estimates.”

Easiest Md/PhD Programs to Get Into Copyright: dolgachov / 123RF Stock Photo

ICON Public Limited Company (NASDAQ:ICLR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 26 hedge fund portfolios held ICON Public Limited Company (NASDAQ:ICLR) at the end of the second quarter which was 30 in the previous quarter.

We discussed ICON Public Limited Company (NASDAQ:ICLR) in another article and shared Polen Capital’s views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q3 2022 page for more investor letters from hedge funds and other leading investors.

 

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire